Background: Plasmid-based measles vaccines offer great promises over the conventional fertilised egg method such as ease of manufacture and mimic wild-type intracellular antigen expression. The increasing number of clinical trials on plasmid-based measles vaccines has triggered the need to make more in less time. Results: In this work, we investigated the process variables necessary to improve the volumetric and specific yields of a model plasmid-based measles vaccine (pcDNA3F) harboured in E. coli DH5α. Results from growth medium optimisation in 500 mL shake flasks by response surface methodology (RSM) generated a maximum volumetric yield of 13.65 mg/L which was 1.75 folds higher than that of the base medium. A controlled fed-batch ferment...
A living cell is a biochemical reactor that allows enzyme-catalyzed reactions to produce a remarkabl...
Plasmid DNA (pDNA) has become very attractive as a biopharmaceutical, especially for gene therapy an...
The use of plasmid DNA (pDNA) for human vaccines is a novel approach against leishmaniasis, a neglec...
Background Plasmid-based measles vaccines offer great promises over the conventional fertilised egg...
Plasmid-based vaccines and therapeutics have been making their way into the clinic in the last years...
The recognition of the potential efficacy of plasmid DNA (pDNA) molecules as vectors in the treatmen...
The recognition of the potential efficacy of plasmid DNA (pDNA) molecules as vectors in the treatmen...
Plasmid DNA (pDNA) vaccine is a promising vaccine technology, with better safety profile, more econo...
Plasmid DNA (pDNA) vaccine is a promising vaccine technology, with better safety profile, more econo...
Progress on plasmid-based (pDNA) vaccines requires simpler and efficient cultivation techniques for ...
Progress on plasmid-based (pDNA) vaccines requires simpler and efficient cultivation techniques for ...
Cell culture production processes are being developed as an alternative to the egg-based influenza v...
The use of plasmid DNA (pDNA) for human vaccines is a novel approach against leishmaniasis, a neglec...
Cell culture production processes are being developed as an alternative to the egg-based influenza v...
Plasmid DNA (pDNA) vaccines are promising means to prevent and treat infectious diseases, such as le...
A living cell is a biochemical reactor that allows enzyme-catalyzed reactions to produce a remarkabl...
Plasmid DNA (pDNA) has become very attractive as a biopharmaceutical, especially for gene therapy an...
The use of plasmid DNA (pDNA) for human vaccines is a novel approach against leishmaniasis, a neglec...
Background Plasmid-based measles vaccines offer great promises over the conventional fertilised egg...
Plasmid-based vaccines and therapeutics have been making their way into the clinic in the last years...
The recognition of the potential efficacy of plasmid DNA (pDNA) molecules as vectors in the treatmen...
The recognition of the potential efficacy of plasmid DNA (pDNA) molecules as vectors in the treatmen...
Plasmid DNA (pDNA) vaccine is a promising vaccine technology, with better safety profile, more econo...
Plasmid DNA (pDNA) vaccine is a promising vaccine technology, with better safety profile, more econo...
Progress on plasmid-based (pDNA) vaccines requires simpler and efficient cultivation techniques for ...
Progress on plasmid-based (pDNA) vaccines requires simpler and efficient cultivation techniques for ...
Cell culture production processes are being developed as an alternative to the egg-based influenza v...
The use of plasmid DNA (pDNA) for human vaccines is a novel approach against leishmaniasis, a neglec...
Cell culture production processes are being developed as an alternative to the egg-based influenza v...
Plasmid DNA (pDNA) vaccines are promising means to prevent and treat infectious diseases, such as le...
A living cell is a biochemical reactor that allows enzyme-catalyzed reactions to produce a remarkabl...
Plasmid DNA (pDNA) has become very attractive as a biopharmaceutical, especially for gene therapy an...
The use of plasmid DNA (pDNA) for human vaccines is a novel approach against leishmaniasis, a neglec...